135 related articles for article (PubMed ID: 1481722)
21. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
Berger DH; O'Mahony CA; Sheng H; Shao J; Albo D; DuBois RN; Beauchamp RD
Surgery; 2003 May; 133(5):568-79. PubMed ID: 12773985
[TBL] [Abstract][Full Text] [Related]
22. Plasminogen activators are involved in the degradation of bone by osteoclasts.
Everts V; Daci E; Tigchelaar-Gutter W; Hoeben KA; Torrekens S; Carmeliet G; Beertsen W
Bone; 2008 Nov; 43(5):915-20. PubMed ID: 18691680
[TBL] [Abstract][Full Text] [Related]
23. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
24. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
Michel JB; Quertermous T
J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387
[TBL] [Abstract][Full Text] [Related]
25. Regulation of urokinase-type plasminogen activator production by rat mammary myoepithelial cells.
Warburton MJ; Dundas SR; Gusterson BA; O'Hare MJ
Exp Cell Res; 1996 Oct; 228(1):76-83. PubMed ID: 8892973
[TBL] [Abstract][Full Text] [Related]
26. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
27. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M
Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
[TBL] [Abstract][Full Text] [Related]
28. Increased bone formation in mice lacking plasminogen activators.
Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
[TBL] [Abstract][Full Text] [Related]
29. Tissue and urokinase plasminogen activators in bone tissue and their regulation by parathyroid hormone.
Leloup G; Peeters-Joris C; Delaisse JM; Opdenakker G; Vaes G
J Bone Miner Res; 1991 Oct; 6(10):1081-90. PubMed ID: 1796756
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.
Hamilton JA; Piccoli DS; Leizer T; Butler DM; Croatto M; Royston AK
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7180-4. PubMed ID: 1908092
[TBL] [Abstract][Full Text] [Related]
31. Post-transcriptional stimulation of transforming growth factor beta 1 mRNA by TGF-beta 1 treatment of transformed human osteoblasts.
Liu C; Wallace K; Shi C; Heyner S; Komm B; Haddad JG
J Bone Miner Res; 1996 Feb; 11(2):211-17. PubMed ID: 8822345
[TBL] [Abstract][Full Text] [Related]
32. Fluoride-stimulated [3H]thymidine uptake in a human osteoblastic osteosarcoma cell line is dependent on transforming growth factor beta.
Reed BY; Zerwekh JE; Antich PP; Pak CY
J Bone Miner Res; 1993 Jan; 8(1):19-25. PubMed ID: 8427046
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the production of plasminogen activators by bone resorption enhancing and inhibiting factors in three types of osteoblast-like cells.
Hoekman K; Löwik CW; vd Ruit M; Bijvoet OL; Verheijen JH; Papapoulos SE
Bone Miner; 1991 Sep; 14(3):189-204. PubMed ID: 1932892
[TBL] [Abstract][Full Text] [Related]
34. Follicular stage-dependent regulation of rat granulosa cell plasminogen activator system by transforming growth factor-alpha in vitro.
Karakji EG; Tsang BK
Biol Reprod; 1995 Feb; 52(2):411-8. PubMed ID: 7711210
[TBL] [Abstract][Full Text] [Related]
35. Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.
Kawao N; Tamura Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E278-88. PubMed ID: 24918201
[TBL] [Abstract][Full Text] [Related]
36. Regulation of proteolytic activity in human bone marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor beta.
Hannocks MJ; Oliver L; Gabrilove JL; Wilson EL
Blood; 1992 Mar; 79(5):1178-84. PubMed ID: 1536945
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts.
Fukumoto S; Allan EH; Zeheb R; Gelehrter TD; Martin TJ
Endocrinology; 1992 Feb; 130(2):797-804. PubMed ID: 1733726
[TBL] [Abstract][Full Text] [Related]
38. Chemotactic response of osteoblastlike cells to transforming growth factor beta.
Pfeilschifter J; Wolf O; Naumann A; Minne HW; Mundy GR; Ziegler R
J Bone Miner Res; 1990 Aug; 5(8):825-30. PubMed ID: 2239366
[TBL] [Abstract][Full Text] [Related]
39. Regulation of plasminogen activator and plasminogen activator inhibitor production by growth factors and cytokines in rat calvarial cells.
Cheng SL; Shen V; Peck WA
Calcif Tissue Int; 1991 Nov; 49(5):321-7. PubMed ID: 1723649
[TBL] [Abstract][Full Text] [Related]
40. In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice.
Marcelli C; Yates AJ; Mundy GR
J Bone Miner Res; 1990 Oct; 5(10):1087-96. PubMed ID: 2080720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
